CN Patent

CN106714770B — 羟基类固醇化合物、其中间体、制备方法、组合物及其用途

Assigned to Sphaera Pharma Pvt Ltd · Expires 2024-04-19 · 2y expired

What this patent protects

本发明涉及新的式(I)类固醇化合物、其制备方法和包含这些化合物的组合物。

USPTO Abstract

本发明涉及新的式(I)类固醇化合物、其制备方法和包含这些化合物的组合物。

Drugs covered by this patent

Ecclock (SOFPIRONIUM BROMIDE) · Kaken Pharmaceutical

Patent Metadata

Patent number: CN106714770B
Jurisdiction: CN
Classification: —
Expires: 2024-04-19
Drug substance claim: No
Drug product claim: No
Assignee: Sphaera Pharma Pvt Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.